Financing Outlook for Florida Life Science and High Tech Companies: An Investor's Point of View
April 18, 2008
You have created a valuable intellectual property asset and assembled a core management team, and now it’s time to secure funding. In this session, a select group of investors and investment bankers in the high-tech and life sciences arena will tell you how they examine and analyze investment opportunities in this space. This discussion will focus on:
- Capital availability for Florida high-tech and life sciences companies (including impact of credit crunch)
- Areas of investor focus
- Lessons from recent deals
- Exit strategies
Related Insights
December 18, 2025
Foley Viewpoints
NAIC Issues Statement Regarding AI Executive Order
On December 16, 2025, the National Association of Insurance Commissioners (NAIC) issued a statement (the NAIC Statement), on the December…
December 17, 2025
Foley Viewpoints
SEC and FINRA Increase Oversight of Cross-Border Small-Cap Offerings
Executive Summary In late 2025, the U.S. Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA)…
December 17, 2025
Foley Viewpoints
Amended Regulation S-P: Here to Stay and Being Examined in 2026
Last month, the U.S. Securities and Exchange Commission (SEC) Division of Examinations released its Fiscal Year 2026 “Examination…